Skip to Content

Outreach

activities

MEDIASRES goes public in several ways: not only will project's results be published in scientific peer-reviewed journals (a record of publications can be found here), but MEDIASRES also aims to reach a broader audience by press releases, articles in popular science journals and newspaper articles as well as personal communications at conferences and workshops. On this page, all different outreach activities including oral and poster presentations at international and local conferences are summarized:

Oral conference contributions by ESRs

2015

  • Azarang L at the 8th International Conference of the ECRIM WG on Computational and Methodological Statistics (ECRIM 2015) in London in December 2015: Direct modeling of regression effects for transition probabilities in the non-Markov illness-death model

  • Susanne Strohmaier at NORDICEPI in Oslo in September 2015: Causal mediation analysis in life-course epidemiology

  • Susanne Strohmaier at ISCB in Utrecht in August 2015: A simple to implement algorithm for natural direct and indirect effects in survival studies with a repeatedly measured mediator

  • Anna Wiksten at ISCB in Utrecht in August 2015: Network meta-analysis combining individual patient data and aggregated data

  • Hong Sun at ISCB in Utrecht in August 2015: Comparing a marker based stratified treatment strategy with the standard treatment in randomized clinical trials

  • Corine Baayen at ISCB in Utrecht in August 2015: A versatile adaptive dose-finding design based on multiple endpoints

  • Soheila Aghlmandi at ISCB in Utrecht in August 2015: Choice of prior distributions in rare events meta-analysis

  • Markus Lange at JSM in Seattle in August 2015: Analysis and Design of clinical trial for biologics using dose-time-response models

  • Hong Sun at ISBS/DIA Symposium on Biopharmaceutical Statistics: Big and Small Data: The Role of Statistics in Drug Development in Beijing in June 2015: Comparing a marker based stratified treatment strategy with the standard treatment in randomized clinical trials

  • Susanne Strohmaier at the Joint meeting of the Italian and Austro-Swiss Region of the International Biometric Society (IROeS) in Milan in June 2015: A simple to implement algorithm for natural direct and indirect effects in survival studies with a repeatedly measured mediator

  • Anna Wiksten at 5th Nordic Baltic Biometric Conference in Reykjavik in June 2015: Network meta-analysis combining individual patient data and aggregated data

  • Markus Lange at Bayes Pharma conference in Basel in May 2015: Bayesian optimal clinical trial design for monoclonal antibodies

  • Corine Baayen at the Novo Nordisk Biostatistics International Meeting in Helsingør in May 2015: Evaluating dose-finding studies under model uncertainty using multiple candidate models

  • Susanne Strohmaier at UK Causal Inference Meeting in Bristol in April 2015: A simple to implement algorithm for natural direct and indirect effects in survival studies with a repeatedly measured mediator

  • Azarang L at the IBS Channel Network Conference in Nijmegen in April 2015: Direct modeling of regression effects for transition probabilities in the non-Markov illness-death model

  • Anna Bellach at ENAR Spring Meeting in Miami in March 2015: Extending Fine and Gray Model: New Approach for Competing Risks Analysis

  •  

2014

  • Azarang L at ECRIM 2014 in Pisa in December 2014: Direct modeling of regression effects for transition probabilities in the progressive illness-death model

  • Alexia Kakourou at Smodia in Crete November 2014: A combination approach to improve predictive performance of diagnostic rules in proteomics

  • Corine Baayen at the joint meeting of the Danish Society for Biopharmaceutical Statistics (DSBS) and the Swedish Association of Medical Statistics (FMS) in October 2014: Testing effect of a drug using multiple nested models for the dose-response

  • Corine Baayen at ISCB in Vienna in August 2014: Confidence bounds for monotone dose-response relationships

  • Mia Klinten Grand at ISCB in Vienna in August 2014: Regression models for the expected length of stay

  • Markus Lange at ISCB in Vienna in August 2014: Bayesian optimal clinical trial design for monoclonal antibodies

  • Matteo Quartagno at ISCB in Vienna in August 2014: Missing data in individual patient data meta-analysis

  • Susanne Strohmaier at ISCB in Vienna in August 2014: Causal mediation analysis in clinical survival trials - can statistics help to understand treatment mechanisms?

  • Hong Sun at ISCB in Vienna in August 2014: Comparing a marker based stratified treatment strategy with the standard treatment in randomized clinical trials

  • Anna Bellach at JSM in Boston in August 2014: Extending Fine and Gray Model: New Approach for Competing Risks AnalysisAbstract

  • Leyla Azarang at 21st International Conference on Computational Statistics (COMPSTAT)in Geneva in August 2014: The jackknife estimate of variance for transition probabilities in the non-Markov illness-death model

  • Corine Baayen at IBC in Florence in July 2014: Confidence bounds for monotone dose-response relationships

  • Federico Bonofiglio at IBC in Florence in July 2014: A meta-analysis procedure for aggregated survival data with competing risks

  • Mia Klinten Grand at IBC in Florence in July 2014: Regression models for the expected length of stay

  • Susanne Strohmaier at IBC in Florence in July 2014: Understanding treatment mechanims in clinical survival trials

  • Markus Lange Bayesian Biostatistics in Zurich in July 2014: Bayesian optimal clinical trial design for monoclonal antibodies

  • Leyla Azarang at Second Conference of the International Society for Non-Parametric Statistics (ISNPS)in Cádiz in June 2014: The jackknife estimate of covariance under censorship when covariables are present

  • Alexia Kakourou at EMGM in Cologne April 2014: A combination approach to improve predictive performance of diagnostic rules in proteomics

  • Susanne Strohmaier at UK Causal Inference Meeting in Cambridge in April 2014: Can we use statistics to understand treatment mechanisms in clinical survival trials?

  • Leyla Azarang at International seminar on Multi-State models in Vigo in March 2014: The jackknife estimate of variance for transition probabilities in the non-Markov illness-death model

  • Hong Sun at 60. Biometrisches Kolloquium in March 2014: Comparing a marker based stratified treatment strategy with the standard treatment in randomized clinical trials

2013

  • Mia Klinten Grand at ECRIM in London in December 2013:Regression models for expected length of stay

  • Markus Lange at ECRIM in London in December 2013:Optimal design of clinical trials with biologics using dose-time-response models

  • Susanne Strohmaier at the Seminar of the Austro-Swiss Region of the International Biometric Society (ROeS) in Dornbirn in September 2013:Understanding treatment effects in clinical survival trials - a causal approach

  • Hong Sun at the Seminar of the Austro-Swiss Region of the International Biometric Society (ROeS) in Dornbirn in September 2013:A framework to assess the added value of subgroup analyses when the overall treatment effect (TE) was significant

  • Susanne Strohmaier at the Seminar of the Austro-Swiss Region of the International Biometric Society (ROeS) in Dornbirn in September 2013:Subgroup selection in clinical trials

  • Hong Sun at ISCB Conference in Munich in August 2013:A framework to assess the added value of subgroup analyses when the overall treatment effect (TE) was significant

  • Susanne Strohmaier at ISCB Conference in Munich in August 2013:Understanding treatment effects in clinical survival trials - a causal approach

  • Corine Baayen at ISCB Conference in Munich in August 2013:Testing effect of a drug using multiple models for the dose-response

  • Markus Lange at ISCB Conference in Munich in August 2013:Optimal design of clinical trials with biologics using dose-time-response models

  • Corine Baayen at JSM Conference in Montreal in August 2013:Testing effect of a drug using multiple models for the dose-response

  • Anna Wiksten at 4th Nordic Baltic Biometric Conference in Stockholm in June 2013: Meta-analysis of clinical trials with heterogeneous sample size and populations

  • Corine Baayen at DAGStat Conference in Freiburg in March 2013:Testing Order-Constrained Hypotheses Concerning Circular Data

  • Federico Bonofiglio at DAGStat Conference in Freiburg in March 2013: Parametric meta-analyses of trials with incomplete reporting of competing events may be performed for cumulative event probabilities

  • Markus Lange at DAGStat Conference in Freiburg in March 2013: Analysis of clinical trials with biologics using dose-time-response models

Other talks by ESRs

  • Anna Wiksten at Novartis Science VC in Basel in September 2015: Network meta-analysis combining individual patient data and aggregated data

  • Anna Wiksten at Statisticians in finnish pharmaceutical industry in Kaarina in May 2015: Network meta-analysis combining individual patient data and aggregated data

  • Corine Baayen presented her project at the University of Southern Denmark in June 2014: Testing effect of a drug using multiple nested models for the dose-response

  • Leyla Azarang during her secondment in Copenhagen at Lundbeck in June 2014: The jackknife estimate of variance for transition probabilities in the non-Markov illness-death model

  • Hong Sun during her secondment in Basel at Novartis Statistical Science Video Conference in April 2014: A framework to assess the added value of subgroup analyses when the overall treatment effect was significant

  • Mia Klinten Grand during her secondment in Copenhagen (UCPH) at Danish Center Institute in June 2014: Dynamic prediction and immortality bias

  • Ketil Biering Tvermosegaard during his secondment at Coordinator's site in Freiburg in June 2014:Optimal Design in NLME models motivated by industrial examples in Reaction Kinetics

  • Alexia Kakourou during his secondment at Coordinator's site in Freiburg in April 2014:Methods for proteomic diagnosis and prognosis in inflammatory diseases

  • Corine Baayen during her secondment at Coordinator's site in Freiburg in December 2013:Revision of the Freiburg Comorbidity Index (FCI) in Multiple Myeloma patients

  • Anna Wiksten during her secondment at Coordinator's site in Freiburg in December 2013:Meta-analysis of aggregated and individual patient data

  • Corine Baayen at Novartis in Basel in November 2013:Testing effect of a drug using multiple nested models for the dose-response

  • Corine Baayen during her secondment at Coordinator's site in Freiburg in November 2013:Testing effect of a drug using multiple nested models for the dose-response

  • Markus Lange at Institute of Biometrics, Medical University Hannover in May 2013:Analysis and design of clinical trials with biologics

Posters by ESRs

2015

  • Anna Wiksten at JSM in Seattle in August 2015: Network meta-analysis combining individual patient data and aggregated data

  • Soheila Aghlmandi at Bayes 2015 at Novartis in Basel in May 2015: Choice of prior distributions in rare events meta-analysis

  • Markus Lange at Design and Analysis of Experiments in Healthcare conference in Cambridge in May 2015: Analysis and Design of clinical trial for biologics using dose-time-response models

2014

  • Alexia Kakourou at ICRM in the Netherlands in September 2014: Combination approached for augmenting predictive performance of diagnostic rules in proteomics

  • Soheila Aghlmandi at ISCB in Vienna in August 2014:Coverage properties of Bayesian 95% probability intervals for odds ratio and relative risk

  • Alexia Kakourou at IBC in Florence in July 2014: Combination approached for augmenting predictive performance of diagnostic rules in proteomics

  • Matteo Quartagno at IBC in Florence in July 2014:Missing data in individual patient data meta-analysis

  • Hong Sun at IBC in Florence in July 2014:Comparing a marker based stratified treatment strategy with the standard treatment in randomized clinical trials

2013

  • Soheila Aghlmandi at 5th GHS Symposium of the Graduate School for Health Sciences in Münchenwiler (CH) in November 2013:Bayesian approaches to analysing adverse events in randomised trials with a high proportion of trial arms observing no event

  • Markus Lange at 7th International Meeting on Statistical Methods in Biopharmacy in Paris in September 2013: Analysis of clinical trials with biologics using dose-time-response models

  • Leyla Azarang at ISCB Conference in Munich in August 2013: Asymptotic results for non-Markov empirical transition probabilities in the illness-death model, with applications

  • Hong Sun at DAGStat Conference in Freiburg in March 2013: A framework to assess the added value of subgroup analyses when the overall treatment effect was significant

Press releases, articles in popular science journals, newspapers or newsletters

Other activities

  • Corine Baayen developed and published a web application for prognosis and treatment-associated risk estimation in patients with multiple myeloma> based on the revised Freiburg comorbidity index, which was developed by the Department of hematology, Oncology and Stem Cell Transplantation of the Medical Center - University of Freiburg

  • Matteo Quartagnon (MEDIASRES ESR) published an R-package called jomo

  • Hong Sun (MEDIASRES ESR) organized a session with the title "Subgroup and subset analysis" at ISBS/DIA Symposium on Biopharmaceutical Statistics: Big and Small Data: The Role of Statistics in Drug Development in Beijing in June 2015

  • MEDIASRES ESRsLeyla Azarang (Vigo) and Mia Klinten Grand (Leiden) presented MEDIASRES and their topics in a joint seminar on multistate-models in February 2015 in Vigo (Spain). Leyla Azarang gave a talk on Direct binomial regression for transition probabilities in the progressive illness-deatk model. Mia Klinten Grand gave a talk on Dynamic prediction by direct binomial regression.

  • Corine Baayen (MEDIASRES ESR) presented herself and her MEDIASRES project in the University Newsletter (Copenhagen) in February 2015

  • MEDIASRES ESRs Mia Klinten Grand and Alexia Kakourou presented MEDIASRES at the 50th anniversary of the Dpt. of Medical Statistics and BioInformatics at Leiden University Medical Center with a poster and flyers plus background material.

  • Disucssion paper by Leyla Azarang (MEDIASRES ESR) presented in an open seminar at University of Vigo in November 2013 and published on the departments website and sent for submission to a JCR journal

  • Book review (on the book Adaptive and Flexible Clinical Trials by Richard Chin) by Philip Hougaard (MEDIASRES supervisor) and Corine Baayen (MEDIASRES ESR), ISCB Newsletter, June 2013

  • Anna Barz (MEDIASRES ESR) presented herself and her MEDIASRES project in the University Newsletter (Copenhagen) in February 2013

  • Corine Baayen (MEDIASRES ESR) and Philip Hougaard (MEDIASRES supervisor) presented the MEDIASRES network and Corine's project at the University of Southern Denmark in November 2012. Abstract

 



about seo